RE:Net Present ValueThe npv would probably be the after tax 20 year oroduct less costs to get the product to the customer including plant costs at a reasonable discount factor
when we have the projected sales etc we can do a calculation
avalyn raised the amount however with a molecule already approved by the fda - their project is an enhanced delivery system for that molecule
The funds providers probably considered the investment was at low risk as in case of failure the molecule could be marketed as a me too
and of high return potentiel if the projet was successful